Literature DB >> 15744305

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Edith M Janssen1, Nathalie M Droin, Edward E Lemmens, Michael J Pinkoski, Steven J Bensinger, Benjamin D Ehst, Thomas S Griffith, Douglas R Green, Stephen P Schoenberger.   

Abstract

The 'help' provided by CD4+ T lymphocytes during the priming of CD8+ T lymphocytes confers a key feature of immune memory: the capacity for autonomous secondary expansion following re-encounter with antigen. Once primed in the presence of CD4+ T cells, 'helped' CD8+ T cells acquire the ability to undergo a second round of clonal expansion upon restimulation in the absence of T-cell help. 'Helpless' CD8+ T cells that are primed in the absence of CD4+ T cells, in contrast, can mediate effector functions such as cytotoxicity and cytokine secretion upon restimulation, but do not undergo a second round of clonal expansion. These disparate responses have features of being 'programmed', that is, guided by signals that are transmitted to naive CD8+ T cells during priming, which encode specific fates for their clonal progeny. Here we explore the instructional programme that governs the secondary response of CD8+ T cells and find that helpless cells undergo death by activation-induced cell death upon secondary stimulation. This death is mediated by tumour-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL). Regulation of Trail expression can therefore account for the role of CD4+ T cells in the generation of CD8+ T cell memory and represents a novel mechanism for controlling adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744305     DOI: 10.1038/nature03337

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  246 in total

1.  NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.

Authors:  Valere Busuttil; Nathalie Droin; Laura McCormick; Francesca Bernassola; Eleonora Candi; Gerry Melino; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance.

Authors:  Melanie P Matheu; Yan Su; Milton L Greenberg; Caroline A Blanc; Ian Parker; David W Scott; Michael D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-17       Impact factor: 11.205

4.  CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.

Authors:  Kamel Ait-Tahar; Amanda P Liggins; Graham P Collins; Andrew Campbell; Martin Barnardo; Maite Cabes; Charles H Lawrie; Donald Moir; Chris Hatton; Alison H Banham; Karen Pulford
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

Review 5.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

6.  CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Authors:  Peter Dias; Francesca Giannoni; Lian Ni Lee; Dongun Han; Sorah Yoon; Hideo Yagita; Miyuki Azuma; Sally R Sarawar
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 7.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

8.  Programming for CD8 T cell memory development requires IL-12 or type I IFN.

Authors:  Zhengguo Xiao; Kerry A Casey; Stephen C Jameson; Julie M Curtsinger; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 9.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

Review 10.  Cancer vaccines: translation from mice to human clinical trials.

Authors:  Hoyoung Maeng; Masaki Terabe; Jay A Berzofsky
Journal:  Curr Opin Immunol       Date:  2018-03-16       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.